Factors Association With Poor Physical Function in Older Adults With Schizophrenia
Status: | Completed |
---|---|
Conditions: | Schizophrenia, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | Any |
Updated: | 9/23/2012 |
Start Date: | March 2010 |
End Date: | November 2013 |
The Impact of Neurocognition and Symptomatology on Physical Function Among Older Adults With Schizophrenia
Older adults with schizophrenia are a growing segment of the population yet their physical
health status is poor. In order to design effective interventions, the contributing factors
must be understood. Current data suggest the side effects of psychiatric medications,
sociodemographic factors, and health care disparities are a few of the reasons for the poor
physical health. There are only limited data on the impact of psychiatric symptomatology and
neurocognition on the physical health of this population. These limited data indicate that
worse symptomatology and poorer neurocognition may negatively impact physical functioning, a
critical component to optimal physical health. The purpose of this pilot study is to begin
to fill this knowledge gap by: 1. examining the relationship between neurocognitive function
and physical function and 2. Examining the relationship between schizophrenia symptoms and
physical function. 3. Examining the relationship between serum Brain Derived Neurotrophic
Factor (BDNF) and physical function. Using a descriptive correlational design, 50 older
adults (55+) with schizophrenia or schizoaffective disorder will be assessed. Bivariate
associations will be used to examine the relationship between key variables including
schizophrenia symptoms as measured by the Positive and Negative Syndrome Scale (PANSS),
neurocognitive function as measured with the MATRICS Consensus Cognitive Battery (MCCB),
Physical Function as measured objectively by the Timed Get Up and Go (TGUG) test and
subjectively with the physical component summary subscale of the 12-item short form health
survey (SF-12), and serum BDNF. These pilot data will lay the foundation for a future
health promoting intervention.
Inclusion Criteria:
- English speaking adults older than or equal to 55 with a DSM-IV diagnosis of
schizophrenia or schizoaffective disorder that pass a capacity to consent test based
on comprehension of the consent form.
Exclusion Criteria:
- Non-English speaking,
- Adults younger than 55,
- No diagnosis of schizophrenia of schizoaffective disorder, and/or
- Not passing a capacity to consent test.
We found this trial at
1
site
500 Parnassus Ave
San Francisco, California 94143
San Francisco, California 94143
(415) 476-9000
University of California at San Francisco (UCSF) The leading university exclusively focused on health, UC...
Click here to add this to my saved trials